BOSTON, Jan. 31 /PRNewswire/ -- Chronic viral hepatitis is a major worldwide health problem with significant long-term morbidity in the form of disease progression to cirrhosis and hepatocellular carcinoma. Great strides have been made in understanding the complex pathogen-host interactions that lead to these serious sequelae. While major therapeutic advances have occurred in the past 15 years in treating chronic viral hepatitis, major unmet medical needs remain in terms of tolerability and efficacy of existing therapies.
Considering this need, ALM’s Strategic Research Institute will bring together global thought leaders from academic and industrial research for two days of focused scientific discussion around emerging discoveries in viral hepatitis. The conference, scheduled for March 12-13, 2007 in Boston, will explore novel therapies for HBV and HCV treatment.
Presenting companies and institutions include: Anadys Pharmaceuticals, Inc., Arrow Therapeutics Ltd, AVI Biopharma, Brown University, GlobeImmune, Inc., Harvard Medical School, Beth Israel Deaconess Medical Center, Hepatitis B foundation, Idenix Pharmaceuticals, InterMune, Inc., Merck, Novartis Institutes for Biomedical Research, Novartis Vaccines & Diagnostics, Pfizer Global Research and Development, Roche, Schering-Plough Corporation and Vertex Pharmaceuticals, Inc.
Early bird pricing ends Friday February 9, 2007, so people interested in attending are encouraged to register early. Companies interested in sponsoring or exhibiting at the meeting should contact Meredith Krantz at 212-967-0095 x218 or email mkrantz@srinstitute.com.
To receive the full agenda in PDF, please contact Seth Fritts of Strategic Research Institute at sfritts@srinstitute.com or 212-967-0095 x256. You can also view the agenda and speakers on the web at: http://www.srinstitute.com/viral.
To become a media partner, please contact Cheryl Kahan-Radhuberat 212-967-0095 x273 ckahan-radhuber@srinstitute.com.
ABOUT STRATEGIC RESEARCH INSTITUTE
The Strategic Research Institute is part of ALM’s Conference and Trade Show Division, one of North America’s largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 300 conferences and two leading industry tradeshows, as well as conferences in Europe and Asia. Attendance at the division’s events, which span a broad range of topics including law, finance, natural resources, life sciences, multi-cultural marketing, real estate and healthcare, will exceed 40,000 executive-level decision makers this year.
ABOUT ALM
Headquartered in New York City, ALM is a leading integrated media company, focused on the legal and business communities. ALM currently owns and publishes 37 national and regional magazines and newspapers, including The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R) and Real Estate Forum(R). Other ALM businesses include Law.com(R), the Web’s leading legal news and information network, Law Journal Press books, newsletter publishing, court verdict and settlement reporting, production of professional educational seminars, market research and content distribution. ALM was formed by U.S. Equity Partners, L.P., a private equity fund sponsored by Wasserstein & Co., LP. More information on ALM’s businesses and services is available on the Web at http://www.alm.com.
Strategic Research Institute
CONTACT: Seth Fritts of Strategic Research Institute, +1-212-967-0095 ext.256, sfritts@srinstitute.com
